In addition, the statements in this press release represent NxStage's
expectations and beliefs as of the date of this press release. NxStage
anticipates that subsequent events and developments may cause these
expectations and beliefs to change. However, while NxStage may elect to
update these forward-looking statements at some point in the future, it
specifically disclaims any obligation to do so, whether as a result of new
information, future events, or otherwise. These forward-looking statements
should not be relied upon as representing NxStage's expectations or beliefs
as of any date subsequent to the date of this press release.
NxStage Medical, Inc.
Consolidated Statements of Operations
(amounts in thousands, except per share data)
Three-months ended Twelve-months ended
December 31, December 31,
2007 2006 2007 2006
Revenues $29,934 $7,353 $59,964 $20,812
Cost of revenues 29,377 8,640 65,967 26,121
Gross profit (deficit) 557 (1,287) (6,003) (5,309)
Operating expenses:
Selling and marketing 6,354 3,742 21,589 14,356
Research and development 2,014 1,690 6,335 6,431
Distribution 4,237 2,257 13,111 7,093
General and administrative 5,206 2,211 13,046 8,704
Total operating expenses
'/>"/>
| SOURCE NxStage Medical, Inc. Copyright©2008 PR Newswire. All rights reserved |